03:55 , Dec 7, 2018 |  BC Innovations  |  Tools & Techniques

Filaments line up as MS biomarker

Neurofilament assays appear on track to become the biomarker of choice for a wide range of neurodegeneration studies, given their tight correlation with axon damage and detectability in blood. If prospective trials can reinforce the...
16:36 , Aug 3, 2018 |  BC Week In Review  |  Clinical News

Banyan reports 97.6% sensitivity for TBI diagnostic

Banyan Biomarkers Inc. (Alachua, Fl.) said data from the ALERT-TBI study showed that its blood-based diagnostic Banyan BTI had 97.6% sensitivity and a 99.6% negative predictive value (NPV) for detecting intracranial injury to rule out...
19:38 , Feb 16, 2018 |  BC Week In Review  |  Clinical News

FDA approves Banyan's brain trauma blood test

FDA approved the Banyan Brain Trauma Indicator (BTI) from Banyan Biomarkers Inc. (Alachua, Fla.) as an in vitro diagnostic blood test to aid in the evaluation of adults with suspected mild traumatic brain injury (TBI)....
07:00 , Jul 21, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Mesencephalic astrocyte-derived neurotrophic factor (MANF; ARP; ARMET)

Ophthalmic disease INDICATION: Ophthalmic disease Mouse and fruit fly studies suggest MANF enhances the effectiveness of cell-based therapies for UV-damaged retinal tissue. In innate immune cells from Drosophila and mice, levels of MANF were higher...
07:00 , Sep 15, 2014 |  BC Week In Review  |  Company News

Banyan Biomarkers, Abbott deal

Banyan granted Abbott undisclosed rights to IP related to traumatic brain injury (TBI) biomarkers for assessment and verification. The companies are not disclosing additional details. Banyan Biomarkers Inc. , Alachua, Fla.   Abbott Laboratories (NYSE:ABT),...
07:00 , Jun 24, 2013 |  BC Week In Review  |  Financial News

Banyan Biomarkers completes venture financing

Banyan Biomarkers Inc. , Alachua, Fla.   Business: Pharmacogenetics   Date completed: 6/20/13   Type: Venture financing   Raised: $6 million   Investors: Private investors  ...
08:00 , Dec 5, 2011 |  BC Week In Review  |  Company News

Amarantus BioSciences Inc., Banyan Biomarkers deal

Amarantus partnered with Banyan to develop Amarantus' mesencephalic astrocyte-derived neurotrophic factor (MANF; ARP; ARMET )-based technology to treat traumatic brain injury (TBI). Banyan will conduct preclinical testing of the technology aimed at developing a companion...
07:00 , Oct 11, 2010 |  BC Week In Review  |  Company News

Banyan Biomarkers, U.S. Department of Defense diagnostic news

Banyan received a four-year $26.3 million contract from the DoD to develop an in vitro diagnostic for traumatic brain injury (TBI). The company is developing three devices for the test, including a desktop assay system,...
23:44 , Oct 5, 2010 |  BC Extra  |  Company News

Banyan receives DoD contract

Banyan Biomarkers Inc. (Alachua, Fla.) received $26.3 million from the U.S. Department of Defense to develop a blood-based diagnostic for traumatic brain injury (TBI)....
08:00 , Feb 15, 2010 |  BC Week In Review  |  Company News

Banyan Biomarkers management update

Banyan Biomarkers Inc. , Alachua, Fla.   Business: Pharmacogenetics   Hired: Jackson Streeter as CEO and CMO, formerly CSO and founder of PhotoThera Inc.  ...